Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35


Temperature-Dependent Development Modeling of the Phorid Fly Megaselia halterata (Wood) (Diptera: Phoridae).

Barzegar S, Zamani AA, Abbasi S, Vafaei Shooshtari R, Shirvani Farsani N.

Neotrop Entomol. 2016 Oct;45(5):507-517.


The Most Common Cow's Milk Allergenic Proteins with Respect to Allergic Symptoms in Iranian Patients.

Shokouhi Shoormasti R, Fazlollahi MR, Barzegar S, Teymourpour P, Yazdanyar Z, Lebaschi Z, Nourizadeh M, Tazesh B, Movahedi M, Kashani H, Pourpak Z, Moin M.

Iran J Allergy Asthma Immunol. 2016 Apr;15(2):161-5.


Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats.

Barzegar S, Komaki A, Shahidi S, Sarihi A, Mirazi N, Salehi I.

Pharmacol Biochem Behav. 2015 Apr;131:87-90. doi: 10.1016/j.pbb.2015.02.005.


The toxic effects of silver nanoparticles on blood mononuclear cells.

Barkhordari A, Barzegar S, Hekmatimoghaddam H, Jebali A, Rahimi Moghadam S, Khanjani N.

Int J Occup Environ Med. 2014 Jul;5(3):164-8.


Twin's sex and risk of pre-term birth.

Haghighi L, Najmi Z, Barzegar SH, Barzegar N.

J Obstet Gynaecol. 2013 Nov;33(8):823-6. doi: 10.3109/01443615.2013.831051.


Cow's milk anaphylaxis in children first report of Iranian Food Allergy Registry.

Teymourpour P, Pourpak Z, Fazlollahi MR, Barzegar S, Shokouhi R, Akramian R, Movahedi M, Mansouri M, Mirsaeedghazi B, Moin M.

Iran J Allergy Asthma Immunol. 2012 Mar;11(1):29-36. doi: 011.01/ijaai.2936.


Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease.

Séllos-Moura M, Barzegar S, Pan L, Shi P, Oommen S, Durant J, Ruiz JA.

J Immunol Methods. 2011 Oct 28;373(1-2):45-53. doi: 10.1016/j.jim.2011.07.020.


Common causes of anaphylaxis in children: the first report of anaphylaxis registry in iran.

Barzegar S, Rosita A, Pourpak Z, Bemanian MH, Shokouhi R, Mansouri M, Cheraghi T, Chavoshzadeh Z, Mohammadzadeh I, Fazlollahi M, Mirsaeedghazi B, Nabavi M, Movahedi M, Gharagozlo M, Farahmand F, Moin M.

World Allergy Organ J. 2010 Jan;3(1):9-13. doi: 10.1097/WOX.0b013e3181c82128.


Non-extraction flow injection determination of cationic surfactants using eriochrome black-T.

Ensafi AA, Hemmateenejad B, Barzegar S.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 Sep 1;73(5):794-8. doi: 10.1016/j.saa.2009.03.030.


Predicting human intestinal permeability using single-pass intestinal perfusion in rat.

Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegar S, Barzegar-Jalali M.

J Pharm Pharm Sci. 2007;10(3):368-79.


Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study.

Furie KL, Rosenberg R, Thompson JL, Bauer K, Mohr JP, Rosner B, Sciacca R, Barzegar S, Thornell B, Costigan T, Kistler JP.

Neurology. 2004 Sep 14;63(5):777-84.


Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

HajMohammadi S, Enjyoji K, Princivalle M, Christi P, Lech M, Beeler D, Rayburn H, Schwartz JJ, Barzegar S, de Agostini AI, Post MJ, Rosenberg RD, Shworak NW.

J Clin Invest. 2003 Apr;111(7):989-99.


Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.

Friederich PW, Levi M, Bauer KA, Vlasuk GP, Rote WE, Breederveld D, Keller T, Spataro M, Barzegar S, Büller HR.

Circulation. 2001 May 29;103(21):2555-9.


Activation of clotting factors XI and IX in patients with acute myocardial infarction.

Minnema MC, Peters RJ, de Winter R, Lubbers YP, Barzegar S, Bauer KA, Rosenberg RD, Hack CE, ten Cate H.

Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2489-93.


Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations.

Bauer KA, Humphries S, Smillie B, Li L, Cooper JA, Barzegar S, Rosenberg RD, Miller GJ.

Thromb Haemost. 2000 Sep;84(3):396-400.


Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.

Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD.

Circulation. 2000 Dec 5;102(23):2816-22.


Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.

Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD.

Thromb Haemost. 1996 May;75(5):767-71.


Factor XIa induced activation of the intrinsic cascade in vivo.

ten Cate H, Biemond BJ, Levi M, Wuillemin WA, Bauer KA, Barzegar S, Buller HR, Hack CE, ten Cate JW, Rosenberg RD.

Thromb Haemost. 1996 Mar;75(3):445-9.


The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.

Miller GJ, Bauer KA, Barzegar S, Foley AJ, Mitchell JP, Cooper JA, Rosenberg RD.

Thromb Haemost. 1995 Jan;73(1):82-6.


Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients.

Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, Rosenberg RD.

Blood. 1994 Aug 15;84(4):1314-9.

Items per page

Supplemental Content

Loading ...
Support Center